Christopher W Schultz

16PUBLICATIONS
125CO-AUTHORS
Tumour immunologyEnglish languageMolecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Oct 23, 2025
Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer.

Christopher W Schultz, Sourav Saha, Anjali Dhall

|Oct 17, 2024
Metastatic organotropism in small cell lung cancer.

Manan Krishnamurthy, Anjali Dhall, Sarthak Sahoo

|Oct 17, 2023
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma.

Francesca M Ponzini, Christopher W Schultz, Benjamin E Leiby

|Jul 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.

Christopher W Schultz, Yang Zhang, Rajaa Elmeskini

|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.

Melissa L Abel, Nobuyuki Takahashi, Cody Peer

Pageof 3

Frequent Collaborators

8 joint publications

Anish Thomas

8 joint publications

Nobuyuki Takahashi

5 joint publications

Brett Schroeder

5 joint publications

Parth Desai